Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19 (June 2020)
Author(s) -
Kimberly E. Hanson,
Angela M. Caliendo,
Cesar Andres Diaz Arias,
Janet A. Englund,
Mark J. Lee,
Mark Loeb,
Robin Patel,
Abdallah El Alayli,
Mohamad A. Kalot,
Yngve FalckYtter,
Valéry Lavergne,
Rebecca L. Morgan,
M. Hassan Murad,
Shahnaz Sultan,
Adarsh Bhimraj,
Reem A. Mustafa
Publication year - 2020
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciaa760
Subject(s) - medicine , covid-19 , pandemic , coronavirus infections , betacoronavirus , virology , medline , intensive care medicine , infectious disease (medical specialty) , outbreak , pathology , disease , political science , law
Accurate molecular diagnostic tests are necessary for confirming a diagnosis of coronavirus disease 2019 (COVID-19). Direct detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acids in respiratory tract specimens informs patient, healthcare institution and public health level decision-making. The numbers of available SARS-CoV-2 nucleic acid detection tests are rapidly increasing, as is the COVID-19 diagnostic literature. Thus, the Infectious Diseases Society of America (IDSA) recognized a significant need for frequently updated systematic reviews of the literature to inform evidence-based best practice guidance.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom